Leukemia - Table of Contents alert Volume 29 Issue 9

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 29, Issue 9 (September 2015) In this issue Original Articles Letters To The Editor Also new AOP Sign up for e-alerts Recommend to your library Web feed Follow on Twitter Subscribe Advertisement Blood Cancer Journal is an online-only, open access journal publishing high quality research on hematologic malignancies and related disorders. The journal has an Impact Factor of 3.467. In support of the Blood Cancer Awareness month, explore the latest research articles or sign up to free e-alerts to receive content straight to your inbox. Original Articles Top CHRONIC LYMPHOCYTIC LEUKEMIA Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia OPEN C Parrish, G B Scott, G Migneco, K J Scott, L P Steele, E Ilett, E J West, K Hall, P J Selby, D Buchanan, A Varghese, M S Cragg, M Coffey, P Hillmen, A A Melcher and F Errington-Mais Leukemia 2015 29: 1799-1810; advance online publication, March 27, 2015; 10.1038/leu.2015.88 Abstract | Full Text The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL K Balakrishnan, M Peluso, M Fu, N Y Rosin, J A Burger, W G Wierda, M J Keating, K Faia, S O'Brien, J L Kutok and V Gandhi Leukemia 2015 29: 1811-1822; advance online publication, April 28, 2015; 10.1038/leu.2015.105 Abstract | Full Text CHRONIC MYELOGENOUS LEUKEMIA Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib F Castagnetti, G Gugliotta, M Breccia, F Stagno, A Iurlo, F Albano, E Abruzzese, B Martino, L Levato, T Intermesoli, P Pregno, G Rossi, F Gherlinzoni, P Leoni, F Cavazzini, C Venturi, S Soverini, N Testoni, G Alimena, M Cavo, G Martinelli, F Pane, G Saglio, G Rosti and M Baccarani on behalf of the GIMEMA CML Working Party Leukemia 2015 29: 1823-1831; advance online publication, June 19, 2015; 10.1038/leu.2015.152 Abstract | Full Text BCR-ABL1 mutation development during first-line treatment with dasatinib or imatinib for chronic myeloid leukemia in chronic phase OPEN T P Hughes, G Saglio, A Quintás-Cardama, M J Mauro, D-W Kim, J H Lipton, M B Bradley-Garelik, J Ukropec and A Hochhaus Leukemia 2015 29: 1832-1838; advance online publication, June 29, 2015; 10.1038/leu.2015.168 Abstract | Full Text IMMUNOTHERAPY Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells L C J te Boome, C Mansilla, L E van der Wagen, C A Lindemans, E J Petersen, E Spierings, K A Thus, K Westinga, M Plantinga, M Bierings, A E C Broers, M L H Cuijpers, G W van Imhoff, J J Janssen, C Huisman, S Zeerleder, G Huls, J J Boelens, N M Wulffraat, I C M Slaper-Cortenbach and J Kuball Leukemia 2015 29: 1839-1846; advance online publication, April 3, 2015; 10.1038/leu.2015.89 Abstract | Full Text LEUKEMOGENESIS Loss of Dnmt3a and endogenous KrasG12D/+ cooperate to regulate hematopoietic stem and progenitor cell functions in leukemogenesis Y-I Chang, X You, G Kong, E A Ranheim, J Wang, J Du, Y Liu, Y Zhou, M-J Ryu and J Zhang Leukemia 2015 29: 1847-1856; advance online publication, March 24, 2015; 10.1038/leu.2015.85 Abstract | Full Text LYMPHOMA Identification of Ezrin-Radixin-Moesin proteins as novel regulators of pathogenic B-cell receptor signaling and tumor growth in diffuse large B-cell lymphoma D Pore, J Bodo, A Danda, D Yan, J G Phillips, D Lindner, B T Hill, M R Smith, E D Hsi and N Gupta Leukemia 2015 29: 1857-1867; advance online publication, March 24, 2015; 10.1038/leu.2015.86 Abstract | Full Text MicroRNA-124 links p53 to the NF-κB pathway in B-cell lymphomas D Jeong, J Kim, J Nam, H Sun, Y-H Lee, T-J Lee, R C T Aguiar and S-W Kim Leukemia 2015 29: 1868-1874; advance online publication, April 27, 2015; 10.1038/leu.2015.101 Abstract | Full Text MULTIPLE MYELOMA Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registry T Bernal, P Martínez-Camblor, J Sánchez-García, R de Paz, E Luño, B Nomdedeu, M T Ardanaz, C Pedro, M L Amigo, B Xicoy, C del Cañizo, M Tormo, J Bargay, D Valcárcel, S Brunet, L Benlloch and G Sanz on behalf of The Spanish Group on Myelodysplastic Syndromes and PETHEMA Foundation, Spanish Society of Hematology Leukemia 2015 29: 1875-1881; advance online publication, May 6, 2015; 10.1038/leu.2015.115 Abstract | Full Text Autocrine amplification of immature myeloid cells by IL-6 in multiple myeloma-infiltrated bone marrow T Matthes, B Manfroi, A Zeller, I Dunand-Sauthier, B Bogen and B Huard Leukemia 2015 29: 1882-1890; advance online publication, June 19, 2015; 10.1038/leu.2015.145 Abstract | Full Text Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia A Ruggeri, M Labopin, G Sanz, S Piemontese, W Arcese, A Bacigalupo, D Blaise, A Bosi, H Huang, D Karakasis, Y Koc, M Michallet, A Picardi, J Sanz, S Santarone, H Sengelov, J Sierra, L Vincent, F Volt, A Nagler, E Gluckman, F Ciceri, V Rocha and M Mohty on behalf of Eurocord, Cord Blood Committee of Cellular Therapy and Immunobiology working party-EBMT, ALWP-EBMT study Leukemia 2015 29: 1891-1900; advance online publication, April 17, 2015; 10.1038/leu.2015.98 Abstract | Full Text MYELODYSPLASTIC SYNDROME Myelopoiesis dysregulation associated to sustained APRIL production in multiple myeloma-infiltrated bone marrow T Matthes, T McKee, I Dunand-Sauthier, B Manfroi, S Park, J Passweg and B Huard Leukemia 2015 29: 1901-1908; advance online publication, March 10, 2015; 10.1038/leu.2015.68 Abstract | Full Text Molecular and phenotypic characterization of CD133 and SSEA4 enriched very small embryonic-like stem cells in human cord blood A Shaikh, P Nagvenkar, P Pethe, I Hinduja and D Bhartiya Leukemia 2015 29: 1909-1917; advance online publication, April 17, 2015; 10.1038/leu.2015.100 Abstract | Full Text STEM CELL TRANSPLANTATION Class IIa HDAC inhibition enhances ER stress-mediated cell death in multiple myeloma S Kikuchi, R Suzuki, H Ohguchi, Y Yoshida, D Lu, F Cottini, J Jakubikova, G Bianchi, T Harada, G Gorgun, Y-T Tai, P G Richardson, T Hideshima and K C Anderson Leukemia 2015 29: 1918-1927; advance online publication, March 24, 2015; 10.1038/leu.2015.83 Abstract | Full Text High concordance of genomic and cytogenetic aberrations between peripheral blood and bone marrow in myelodysplastic syndrome (MDS) A M Mohamedali, J Gäken, M Ahmed, F Malik, A E Smith, S Best, S Mian, T Gaymes, R Ireland, A G Kulasekararaj and G J Mufti Leukemia 2015 29: 1928-1938; advance online publication, May 6, 2015; 10.1038/leu.2015.110 Abstract | Full Text Letters To The Editor Top Radotinib is an effective inhibitor of native and kinase domain-mutant BCR-ABL1 M S Zabriskie, N A Vellore, K C Gantz, M W Deininger and T O'Hare Leukemia 2015 29: 1939-1942; advance online publication, February 13, 2015; 10.1038/leu.2015.42 Full Text Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q M Heuser, M Meggendorfer, M M A Cruz, J Fabisch, S Klesse, L Köhler, G Göhring, C Ganster, K Shirneshan, A Gutermuth, S Cerny-Reiterer, J Krönke, V Panagiota, C Haferlach, C Koenecke, U Platzbecker, C Thiede, T Schroeder, G Kobbe, S Ehrlich, K Stamer, K Döhner, P Valent, B Schlegelberger, N Kroeger, A Ganser, D Haase, T Haferlach and F Thol Leukemia 2015 29: 1942-1945; advance online publication, February 24, 2015; 10.1038/leu.2015.49 Full Text Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma N Shah, P F Thall, P S Fox, Q Bashir, J J Shah, S Parmar, P Lin, P Kebriaei, Y Nieto, U R Popat, C M Hosing, A Cornelison, E J Shpall, R Z Orlowski, R E Champlin and M H Qazilbash Leukemia 2015 29: 1945-1948; advance online publication, February 27, 2015; 10.1038/leu.2015.54 Full Text Notch-mediated expansion of cord blood progenitors: maintenance of transcriptional and epigenetic fidelity A Dahlberg, S Woo, C Delaney, P Boyle, A Gnirke, C Bock, B E Bernstein, A Meissner, R Gottardo and I D Bernstein Leukemia 2015 29: 1948-1951; advance online publication, March 6, 2015; 10.1038/leu.2015.61 Full Text The immunosuppressive ligands PD-L1 and CD200 are linked in AML T-cell immunosuppression: identification of a new immunotherapeutic synapse S J Coles, M N Gilmour, R Reid, S Knapper, A K Burnett, S Man, A Tonks and R L Darley Leukemia 2015 29: 1952-1954; advance online publication, March 9, 2015; 10.1038/leu.2015.62 Full Text Efficacy and toxicity of dexamethasone vs methylprednisolone—long-term results in more than 1000 patients from the Russian randomized multicentric trial ALL-MB 2002 A Karachunskiy, J Roumiantseva, S Lagoiko, C Bührer, G Tallen, O Aleinikova, O Bydanov, N Korepanova, L Bajdun, T Nasedkina, A von Stackelberg, G Novichkova, A Maschan, D Litvinov, N Myakova, N Ponomareva, K Kondratchik, L Fechina, O Streneva, N Judina, G Scharapova, A Shamardina, I Gerbek, A Shapochnik, A Rumjanzew and G Henze for the ALL-MB study group Leukemia 2015 29: 1955-1958; advance online publication, March 9, 2015; 10.1038/leu.2015.63 Full Text Advertisement The British Journal of Cancer presents four special Web Focuses in key areas of interest. Click on the links below to access each focus for free. Web Focus on Systemic Inflammation as a Prognostic Marker in Cancer  Web Focus on Melanoma, the Great Leap Forward Web Focus on New Drugs to Watch Web Focus on The Changing Landscape of Breast Cancer Prognostic Prediction   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Leukemia. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.